Baseline serum sitosterol level as predictor of adverse clinical events in acute coronary syndrome patients with dyslipidaemia: A sub-analysis of HIJ-PROPER

Junichi Yamaguchi(Tokyo Women's Medical University), Nobuhisa Hagiwara(Tokyo Women's Medical University), Kunihiko Matsui(Kumamoto University), Hiroshi Ogawa(Kumamoto University), Erisa Kawada‐Watanabe(Tokyo Women's Medical University), Haruki Sekiguchi(Tokyo Women's Medical University), Ryo Koyanagi(Tokyo Women's Medical University), Kōichi Nakao(Kanazawa Seiryo University), Tatsuro Uchida(Sendai Medical Center), Yasuhiro Endo(National Defense Medical College), Hiroyuki Tanaka(Tokyo Metropolitan Tama Medical Center), Kozue Saito, Hiroyuki Arashi(Tokyo Women's Medical University), Toshiaki Oka(Seirei Hamamatsu General Hospital), Tetsuya Tobaru(Sakakibara Hospital)
Atherosclerosis
May 5, 2018
10.1016/j.atherosclerosis.2018.04.036
Cited by 30

Related Papers

Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
|Circulation|1994|1.3k
Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis
|The Lancet|2021|997
Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI
|JAMA|2019|848
JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome
|Circulation Journal|2019|582
Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention
|Journal of the American College of Cardiology|2015|453